Since both, metastatic invasive lobular carcinoma of the breast and primary endometrial carcinoma demonstrate positivity for ER and PR, immunostaining for hormone receptors is not helpful in distinguishing tumors of metastatic mammary origin from those of primary endometrial origin. The gene discussed is NR4A1; the disease is endometrial carcinoma.